Medical Week News v. Sanofi-Aventis

June 27 2005

EFF has filed a lawsuit against French pharmaceutical giant Sanofi-Aventis Group on behalf of Medical Week News publishers of the medical news website Sanofi-Aventis the world's third largest pharmaceutical company threatened Medical Week News with legal action based on its use of the word "Acomplia" in its website domain name.

Acomplia is the name of a Sanofi-Aventis drug intended to combat obesity and assist with smoking cessation that has shown promise in clinical trials in the United States in Europe and has just been submitted to the US FDA and European regulators for approval. is an independent online newsletter devoted to reporting news about the drug.

In the lawsuit filed in US District Court in San Francisco Medical Week News asserts its fair use right to use the word "Acomplia" in publishing independent news about the forthcoming drug. It asks the court to declare that Medical Week News is entitled to continue to use the word "Acomplia" in the domain name and website.

Stay in Touch

NSA Spying

EFF is leading the fight against the NSA's illegal mass surveillance program. Learn more about what the program is, how it works, and what you can do.

Follow EFF

The TPP negotiations have ended but the fight to stop it is far from over. Here's how we're going to defeat it:

Dec 1 @ 5:14pm

First-ever complete unmasking of FBI national security letter shows scope of spying, need for NSL challenges:

Dec 1 @ 3:59pm

Volume 4.0 of Digital Citizen features a discussion on refugees and technology:

Dec 1 @ 3:19pm
JavaScript license information